Efficacy and safety of once-monthly Risperidone ISM ® in schizophrenic patients with an acute exacerbation

Information
Discussion (0)
Usage statistics

Efficacy and safety of once-monthly Risperidone ISM ® in schizophrenic patients with an acute exacerbation - Correll, Christoph U. (Charité - Universitätsmedizin Berlin) ; Litman, Robert E. (Georgetown University Medical School. Department of Psychiatry) ; Filts, Yuriy (Lviv Regional Clinical Psychiatric Hospital) ; Llaudó, Jordi (Laboratorios Farmacéuticos ROVI. Medical Department) ; Naber, Dieter (Hamburg-Eppendorf University. Department of Psychiatry and Psychotherapy) ; Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Martínez, Javier (Laboratorios Farmacéuticos ROVI. Medical Department)

Comments (0) | Reviews (0)

Be the first to review this document.

Add review

Rate this article:

Give a title to your review:

Write your review:

Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.

Similar records